• Chenodeoxycholic Acid: FXR Evidence & Research Use

  2026-09-24

  Chenodeoxycholic Acid (CDCA) is a primary bile acid and FXR activator used to investigate bile acid metabolism and nuclear receptor signaling. A 2026 preclinical study reports that CDCA activated an FXR–KLF11 pathway associated with reduced kidney injury in mouse and cell models, but does not establish clinical efficacy.

• Patient-Derived Spheroids Model Localized Prostate Cancer

  2026-09-24

  This study established viable, cryopreservable three-dimensional spheroid cultures from radical prostatectomy tissue across 109 cases, addressing a shortage of models for organ-confined prostate cancer. The spheroids retained several prostate epithelial markers and showed distinct responses to tested drugs, while their lack of response to abiraterone highlights the need to assess drug activity in the context of each model’s biology.

• miR-196a Drives EAC Through the MYC/TERT/NFκB Axis

  2026-09-23

  A 2025 study links miR-196a to epithelial-to-mesenchymal transition, greater motility, and NFκB activation in esophageal adenocarcinoma cells. Its experiments support a signaling model in which reduced VCP and NFKBIA expression connect miR-196a with c-MYC accumulation, TERT upregulation, and more aggressive cell behavior.

• Cyanine 5-dCTP for DNA Fluorescent Probe Synthesis

  2026-09-23

  Cyanine 5-dCTP adds a red-fluorescent handle to enzymatically produced DNA, supporting PCR labeling, probe construction, and nucleic acid detection. This guide combines practical incorporation strategies with the ordered DNA-framework concept reported for higher-yield enzymatic oligonucleotide synthesis.

• Human iPSC Models for Schizophrenia and Bipolar Disorder

  2026-09-22

  This resource study established and characterized three human induced pluripotent stem cell lines from two cousins with schizophrenia or bipolar disorder and an unaffected cousin. The family-linked design provides a practical foundation for investigating neurodevelopmental mechanisms, although disease-relevant neuronal phenotypes and molecular comparisons remain to be developed.

• Repeated Degarelix Treatment in Goats: Study Insights

  2026-09-22

  This 2020 study found that repeated subcutaneous degarelix acetate treatment produced sustained suppression of testosterone and INSL3, reduced testicular measures, and eliminated detectable sperm in young male goats. The work extends GnRH receptor antagonist research from short-term endocrine suppression to a multidimensional assessment of chemical castration, while also defining important limits for translation to other reproductive or clinical settings.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-09-21

  Zhou et al. identify TSPAN18 as a regulator of STIM1 stability, showing that it protects STIM1 from TRIM32-mediated ubiquitination and sustains calcium entry linked to prostate cancer bone metastasis. The study connects protein-protection mechanisms with metastatic behavior and provides a framework for investigating the TSPAN18–STIM1–Ca2+ axis in follow-up models.

• Vardenafil HCl Trihydrate for Proteoform PDE5 Research

  2026-09-21

  Vardenafil HCl Trihydrate supports a connected workflow spanning PDE5 inhibition, cGMP signaling, smooth muscle assays, and proteoform-aware off-target analysis. Its strong PDE5 potency and defined PDE isoform selectivity make it useful for separating target biology from PDE6-related observations in native membrane systems.

• Direct Mouse Genotyping Kit Plus for Atherosclerosis

  2026-09-20

  Build faster, purification-free mouse genotyping workflows for transgene screening, knockout validation, and complex atherosclerosis cohorts. The Direct Mouse Genotyping Kit Plus combines direct tissue lysate preparation with a dye-containing high-fidelity PCR mix, helping laboratories connect genotype assignments to macrophage and plaque phenotypes with fewer handling steps.

• TCF25 Links V-ATPase to Lysosomal Cell Death

  2026-09-19

  Ren et al. identify TCF25 as a nutrient sensor that couples glucose-starvation adaptation to lysosome-dependent cell death by regulating V-ATPase-associated acidification. Their CRISPR-Cas9, mechanistic, and mouse ischemia-reperfusion studies define a context-dependent lysosomal pathway with implications for metabolic stress research.

• Concanamycin A: V-ATPase Assay Workflows

  2026-09-18

  Build sharper lysosomal-stress and tumor-cell assays with Concanamycin A, a nanomolar V-type H+-ATPase inhibitor for dissecting acidification, trafficking, apoptosis, and invasion. This workflow connects acute V-ATPase inhibition to the AMPK–SQSTM1/p62–NRF2 stress circuitry highlighted in recent cancer biology research.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-09-18

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome activity, BRCA1/FANC cassette exons, and DNA-damage repair in hepatocellular carcinoma. The work shows that SmD2 depletion or HDAC-inhibitor treatment can increase sensitivity to PARP inhibition, providing a mechanistic rationale for combination treatment in HCC models.

• Abiraterone Acetate in Translational Prostate Cancer

  2026-09-17

  A thought-leadership guide to using Abiraterone acetate as a CYP17 inhibitor in prostate cancer research, with strategic lessons from patient-derived three-dimensional spheroids, model selection, assay design, and translational interpretation.

• MDV3100 in Enzalutamide Resistance Research

  2026-09-17

  MDV3100 enables more than a viability readout: it connects androgen receptor blockade with glycan remodeling, motility, spheroid growth, and therapeutic resistance. This workflow shows how to use Enzalutamide in prostate cancer models while separating acute AR responses from durable metabolic and phenotypic adaptations.

• LY2228820: Practical p38 MAPK Workflow Guide

  2026-09-16

  LY2228820 enables mechanism-focused studies of inflammatory signaling, tumor-cell stress, and angiogenic responses through selective p38α/β inhibition. This workflow guide connects target engagement, phosphatase-aware assay design, combination testing, and troubleshooting for more interpretable preclinical data.

8549 records 1/570 page Next 12345 下5页 Last page